Literature DB >> 22900621

A retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie's disease: measured lengths and patient perceptions.

James Rybak1, Dimitri Papagiannopoulos, Laurence Levine.   

Abstract

INTRODUCTION: Loss of penile length is a recognized and common consequence of Peyronie's disease (PD). Traction therapy (TT+) has been reported to decrease post-op length loss as well as increase stretched penile length (SPL) prior to surgery. AIM: The aim of this study was to study patient outcomes with penile length change and patient satisfaction after surgery following tunica albuginea plication (TAP) and partial plaque excision and grafting (PEG) with or without postoperative TT.
METHODS: Retrospective analysis was performed from our cohort of Peyronie's reconstructive surgery between 2007 and 2010. SPL was measured dorsally from pubis to corona and recorded at the initial office visit and then compared to most recent postoperative visit. Patients were then stratified by procedure and whether TT was used (TT+ and TT-; TAP N = 52 [27 TT+ and 25 TT-] and PEG N = 59 [36 TT+ and 23 TT-). Traction therapy was initiated for >2 hours a day for 3 months typically starting 3-4 weeks postoperatively. A non-validated mailed questionnaire assessed patient perceptions.
RESULTS: Mean length change seen in TAP (TT+) was 0.85 cm (0.25-1.75) vs. -0.53 cm (-1.75 to 0.5) in TAP (TT-) (P < 0.001). The mean length change seen in PEG (TT+) was 1.48 cm (0-6) vs. PEG (TT-) 0.24 cm (-1 to 2.5 cm) (P < 0.001). Sixty-one percent of surveys were returned; 85% lost length prior to the initial office evaluation, with an average of -2.5 cm lost. Importantly, in those who used traction, there was no perceived length loss, 58% reported a mean erect length gain of 1.1 cm. However, only 54% of all patients were satisfied with their current erect length.
CONCLUSIONS: Loss of length in men with PD remains a serious concern. It appears that postoperative TT can result in length preservation, and in many, a measured and perceived length gain following correction of the curvature.
© 2012 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22900621     DOI: 10.1111/j.1743-6109.2012.02849.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  17 in total

Review 1.  Contemporary Review of Peyronie's Disease Treatment.

Authors:  Edward Capoccia; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

2.  2018 Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature.

Authors:  Anthony J Bella; Jay C Lee; Ethan D Grober; Serge Carrier; Francois Benard; Gerald B Brock
Journal:  Can Urol Assoc J       Date:  2018-02-22       Impact factor: 1.862

Review 3.  Surgical management of Peyronie's disease.

Authors:  Uwais B Zaid; Amjad Alwaal; Xiaoyu Zhang; Tom F Lue
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

Review 4.  2013-2014 updates in Peyronie's disease management.

Authors:  Benjamin A Sherer; Krishnan Warrior; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2014-12       Impact factor: 3.092

Review 5.  Indications and characteristics of penile traction and vacuum erection devices.

Authors:  Abida Sultana; Peter Grice; Josip Vukina; Ian Pearce; Vaibhav Modgil
Journal:  Nat Rev Urol       Date:  2021-11-11       Impact factor: 14.432

6.  Commentary on the myths of Peyronie's disease.

Authors:  Alex K Wu; Tom F Lue
Journal:  Transl Androl Urol       Date:  2012-12

7.  Surgical Management for Peyronie's Disease.

Authors:  Robert L Segal; Arthur L Burnett
Journal:  World J Mens Health       Date:  2013-04-23       Impact factor: 5.400

Review 8.  Peyronie's disease: A contemporary review of non-surgical treatment.

Authors:  Laurence A Levine
Journal:  Arab J Urol       Date:  2013-05-28

Review 9.  Penile traction therapy for Peyronie's disease-what's the evidence?

Authors:  Mustafa Faruk Usta; Tumay Ipekci
Journal:  Transl Androl Urol       Date:  2016-06

Review 10.  Lengthening strategies for Peyronie's disease.

Authors:  Christopher D Gaffney; Matthew J Pagano; Aaron C Weinberg; Alex C Small; Franklin E Kuehas; Paulo H Egydio; Robert J Valenzuela
Journal:  Transl Androl Urol       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.